Home > Boards > US Listed > Biotechs >

ProNAi Therapeutics Inc (SRRA)

Add SRRA Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/8/2019 7:15:20 AM - Followers: 32 - Board type: Free - Posts Today: 0

A clinical-stage oncology company pioneering a novel class of therapeutics based on our proprietary DNA interference (DNAi®) technology platform.

Their vision is to be the leader in developing and commercializing a portfolio of DNAi-based therapies to deliver extraordinary therapeutic outcomes that dramatically change patients’ lives.

Their lead DNAi product candidate, PNT2258, targets BCL2, a widely overexpressed oncogene that is an important gatekeeper of the programmed cell death process known as apoptosis and has been linked to many forms of cancer. They believe the preliminary evidence of efficacy, safety and tolerability observed to date suggest that PNT2258 has the potential to change treatment paradigms across a wide range of oncology indications. They recently initiated Wolverine, a Phase 2 trial for the treatment of third-line relapsed or refractory DLBCL, and by mid-2015, we plan to initiate Brighton a Phase 2 trial for the treatment of Richter’s.


ProNAi to Present at Jefferies Autumn 2015 Global Healthcare Conference in London

VANCOUVER, Nov. 11, 2015 /CNW/ - ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today announced that Dr. Nick Glover, President and Chief Executive Officer, will present an overview of the company at the Jefferies Autumn 2015 Global Healthcare Conference in London.

The presentation is scheduled for 4:40 pm (GMT) on Thursday, November 19th. A live webcast of the presentation will be accessible through the ProNAi website at www.pronai.com.  An archived replay of the presentation will also be available.

About ProNAi Therapeutics
ProNAi Therapeutics is a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform for patients with cancer and hematological diseases. ProNAi's lead DNAi product candidate, PNT2258, is designed to treat cancers that overexpress BCL2, an important and validated oncogene known to be dysregulated in many types of cancer. ProNAi is pursuing a multi-faceted clinical development strategy designed to efficiently achieve regulatory approval and maximize the commercial opportunity of PNT2258. ProNAi is actively enrolling patients in "Wolverine", a Phase 2 trial evaluating PNT2258 for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and in "Brighton", a Phase 2 trial evaluating PNT2258 for the treatment of Richter's transformation. For more information, please visitwww.pronai.com.

Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding ProNAi's anticipated clinical development activities, including the design, timing and outcome of such activities. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements are subject to risks and uncertainties, including, among others, the risk that ProNAi may be unable to successfully develop and commercialize PNT2258 or any other future product candidates, PNT2258 may fail to demonstrate safety and efficacy or may not otherwise produce positive results, ProNAi may experience delays in clinical trials, including due to difficulties enrolling patients, ProNAi's third-party manufacturers may cause its supply of materials to become limited or interrupted or fail to be of satisfactory quantity or quality,
ProNAi's cash resources may be insufficient to fund its current operating plans and it may be unable to raise additional capital when needed, ProNAi may be unable to obtain and enforce intellectual property protection for its technologies and product candidates and the other factors described under the heading "Risk Factors" set forth in ProNAi's filings with the Securities and Exchange Commission from time to time, including the Company's reports filed with the Securities and Exchange Commission. ProNAi undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#335   Any idea when they plan on filing an bUrRpPPP! 05/08/19 07:15:20 AM
#334   Today's presentation is up -- JenningsB 04/01/19 07:59:25 PM
#333   late-breaking oral presentation at the American Association of RNsidersbuying 03/28/19 12:44:40 PM
#332   Incase anyone missed this PR. Luis Hernandez 03/20/19 02:16:24 AM
#331   $SRRA NICE SETUP SkipDawg 02/10/19 08:42:57 PM
#330   What do you think is a good entry Xpedian 11/25/18 03:39:04 PM
#329   50MA @ 1.74 last resistance before nice move bUrRpPPP! 11/18/18 01:33:52 PM
#328   SRRA why I bought...article link... bUrRpPPP! 11/05/18 10:24:58 AM
#327   SRRS ASH DEC 2-4 INFO bUrRpPPP! 11/05/18 10:13:41 AM
#326   SRRA CHART Grabbed a starter $1.73 trading @ bUrRpPPP! 10/30/18 05:24:35 PM
#325   $SRRA GONNA RUN LIKE A RAPED APE! $125 SkipDawg 10/16/18 09:57:28 PM
#324   $SRRA - add any dips and ride this SkipDawg 09/21/18 09:18:26 AM
#323   $SRRA creeping up. Setting up nice technically and SkipDawg 09/20/18 01:20:43 PM
#322   * * $SRRA Video Chart 09-05-18 * * ClayTrader 09/05/18 04:46:28 PM
#321   SRRA...$1.76...Oversold Pincher Chart...Bullish Harami Reversal Pattern...Macd C georgie18 09/02/18 03:04:17 PM
#320   Dead board but I have a nice average lol BuynowCryLater 06/13/18 05:25:17 PM
#319   if you want good exposure skez13 02/06/18 08:29:04 AM
#318   Presentation today The company is presenting today in Boston dockside130 02/01/18 10:29:12 AM
#317   Strong finish today. Run up to the nferna 01/26/18 04:56:17 PM
#316   Sierra Oncology Says Cancer Drug has Big Potential JenningsB 11/17/17 01:34:48 PM
#315   This board is dead and so is this BuynowCryLater 11/14/17 12:48:11 AM
#314   * * $SRRA Video Chart 10-25-17 * * ClayTrader 10/25/17 05:25:56 PM
#313   No way unless the crap CEO turns off Value_Investor 07/14/17 04:43:24 PM
#312   Sell now (at $1.xx) is much much better Value_Investor 07/14/17 04:41:51 PM
#311   Because the OS keeps getting bigger and bigger Value_Investor 07/14/17 04:39:28 PM
#310   Another New 52-week low $1.1 was created! More Value_Investor 07/14/17 04:37:55 PM
#309   $SRRA long 1000 starter @ 1.13 beat down bio MONSTAMONEYMOVA 06/15/17 02:24:44 PM
#308   Just some Canadians dodging lawsuits BuynowCryLater 05/05/17 02:52:38 PM
#307   Yes it seems that way Peabody27 04/11/17 05:30:34 PM
#306   Dead board and stock ? BuynowCryLater 04/11/17 12:33:57 PM
#305   I'm wondering the same lol ... BuynowCryLater 01/30/17 03:01:41 PM
#304   Any hope for this one? PStockPickz 12/11/16 10:02:03 AM
#303   Free willy shurtha2000 12/09/16 10:31:58 AM
#302   ready to bust a move shurtha2000 12/09/16 10:11:12 AM
#301   Here we go! harmsen 12/06/16 01:24:59 PM
#300   DNAI Trading Way to Cheap These Sellers are Stockexpertpro 12/06/16 10:24:10 AM
#299   Added for quick play! DEADSKY 12/02/16 11:56:26 AM
#298   Gonna open +60% one of these days, easy Giovinco 11/03/16 12:09:55 PM
#297   Still just watching it,looking for bottom. sick nam vet 11/02/16 04:17:01 PM
#296   Been reading the latest SEC Filings seen the Stockexpertpro 11/02/16 04:00:25 PM
#295   GAME OVER BAGHOLDERS YOU LOSE SELL SELL SELL Stockexpertpro 11/02/16 03:49:42 PM
#294   THis one just keeps getting worst and worst,on sick nam vet 10/28/16 12:01:56 PM
#293   Man this used to be a money maker,hope sick nam vet 10/25/16 12:37:36 PM
#292   Another New low $1.62 just hit! DNAI is Value_Investor 10/25/16 12:02:32 PM
#291   Back on my watch list. sick nam vet 10/25/16 11:37:19 AM
#290   New low of year today. sick nam vet 10/25/16 11:36:35 AM
#289   yes but now it's so extreme compared to Giovinco 10/24/16 12:51:30 PM
#288   LOL this pos is being pumped every where spottrader 10/24/16 12:29:52 PM
#287   More than $4 Cash Easy huge gain long Giovinco 10/24/16 11:48:03 AM
#286   Another New 52-week low $1.63 was created today! Value_Investor 10/24/16 10:33:34 AM